Evidence map›Paper›PMID 27016651›Full record

ArticleVaccine2016

Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions.

Mana Mahapatra, Bob Statham, Yanmin Li, Jef Hammond, David Paton, Satya Parida

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Vaccine matching and antigenic variability of foot-and-mouth disease virus serotypes O and A from 2018 Ethiopian isolates.International microbiology : the official journal of the Spanish Society for Microbiology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mana MahapatraThe Pirbright Institute, Ash Road, Woking, Surrey GU24 0NF, UK. Electronic address: mana.mahapatra@pirbright.ac.uk.
Bob StathamThe Pirbright Institute, Ash Road, Woking, Surrey GU24 0NF, UK.
Yanmin LiThe Pirbright Institute, Ash Road, Woking, Surrey GU24 0NF, UK.
Jef HammondThe Pirbright Institute, Ash Road, Woking, Surrey GU24 0NF, UK.
David PatonThe Pirbright Institute, Ash Road, Woking, Surrey GU24 0NF, UK.
Satya ParidaThe Pirbright Institute, Ash Road, Woking, Surrey GU24 0NF, UK.
The Pirbright Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F009186/1Biotechnology and Biological Sciences Research Council BB/H009175/1
6 · The paper itself

Abstract

A new immunologically distinct strain (A-Iran-05) of foot-and-mouth disease virus serotype A emerged in the Middle East in 2003 that replaced the previously circulating strains (A-Iran-96 and A-Iran-99) in the region. This resulted in introduction of a new vaccine of this strain (A/TUR/2006) in 2006. Though this vaccine strain has been predominantly used to control FMD in the region, recent viruses isolated in 2012 and 2013 have shown antigenic drift and a poor match with it. In this study, we report the antigenic matching results and capsid sequence data of currently circulating viruses belonging to the SIS-10 and SIS-12 sub-lineages of A-Iran-05 (isolated in 2012 and 2013), highlighting the inadequacy of the currently used serotype A vaccines. Implications of these results in the context of FMD control in the Middle East are discussed.

Indexed as

Antigenic VariationAmino Acid SequenceAnimalsAntibodies, NeutralizingAntigens, ViralCapsid ProteinsCattleCross ReactionsFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusImmune SeraMiddle EastNeutralization TestsProtein Structure, TertiarySerogroupAntibodies, NeutralizingAntigens, ViralCapsid ProteinsImmune SeraAntigenic determinantsAntigenic variationCapsid sequenceEpitopesFMD virusPolyclonal antibodies

Identifiers

PMID27016651
PMCPMC4912224
OpenAlexW2302905190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.